跳至主要内容
临床试验/NCT07534969
NCT07534969已完成不适用

Fixed-time Interval vs. On-demand Analgesia Following Vacuum-assisted Vaginal Delivery: A Randomized Controlled Trial

Yael Yagur1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2024年9月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
51
试验地点
1
主要终点
Scheduled versus on-demand pain relief protocols following vacuum-assisted delivery during the first 24 hours postpartum

研究概览

简要总结

This randomized controlled trial evaluates the effectiveness of scheduled versus on-demand pain relief protocols in managing postpartum pain during the first 24 hours after vacuum-assisted delivery.

Objectives:

Primary: Compare pain reduction (VAS scores) between the two protocols. Secondary: Assess extended pain relief use, breastfeeding rates, maternal satisfaction, and postpartum hospitalization duration.

Design:

Participants: 200 women aged 18-45, randomized into two groups:

Scheduled Pain Relief: Acetaminophen and diclofenac every 8 hours. On-Demand Pain Relief: Same medications administered upon request. Pain levels are assessed via VAS every 8 hours and around medication times. All participants receive IV acetaminophen immediately postpartum and additional pain relief for breakthrough pain as needed.

Data Collection: Demographics, delivery details, pain scores, medication use, breastfeeding rates, and satisfaction (using the Birth Satisfaction Scale-BSS-R) will be recorded.

Significance: The study aims to fill a gap in the literature on postpartum pain management for vacuum-assisted deliveries, improving care and maternal outcomes.

详细描述

Study Objectives:

  1. Primary Objective: Compare the effectiveness of scheduled versus on-demand pain relief protocols following vacuum-assisted delivery during the first 24 hours postpartum, using the VAS (Visual Analog Scale) for pain (1-10).
  2. Secondary Objectives:
  • Measure VAS scores every 8 hours during the first 24 hours postpartum.
  • Assess the use of pain relief beyond 24 hours postpartum, including the use of morphine.
  • Evaluate breastfeeding rates, satisfaction with the birth experience, and length of postpartum hospitalization.

Study Design:

  • Recruitment: Women will be recruited immediately after vacuum-assisted delivery.
  • Participants will provide informed consent and be assigned a unique anonymous identifier for data collection.
  • All participants will receive 1,000 mg of IV acetaminophen immediately postpartum, per departmental protocol.
  • Participants will be randomized (1:1) into two groups:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 18-45 who underwent vacuum-assisted delivery of a singleton pregnancy.

排除标准

  • Allergy to acetaminophen or NSAIDs.
  • Chronic pain conditions (e.g., endometriosis, fibromyalgia).
  • Cesarean deliveries.
  • Multiple pregnancies.
  • Normal vaginal delivery.

研究组 & 干预措施

Scheduled Pain Relief

Active Comparator

Scheduled Pain Relief

干预措施: Scheduled Pain relief drugs administered during the first 24 hours postpartum every 8 hours. (Drug)

On-Demand Pain Relief Group

Placebo Comparator

pain relief drug by request

干预措施: On demand analgesia (Other)

结局指标

主要结局

Scheduled versus on-demand pain relief protocols following vacuum-assisted delivery during the first 24 hours postpartum

时间窗: From enrollment until discharge following delivery, up to 1 week.

Compare the effectiveness of scheduled versus on-demand pain relief protocols following vacuum-assisted delivery during the first 24 hours postpartum, using the VAS (Visual Analog Scale) for pain (1-10).

次要结局

  • Pain relif use, hospitalization, breastfeeding and maternal satisfaction.(From enrollment until discharge following delivery, up to 1 week.)
  • Baseline maternal and obstetric characteristics(From enrollment until discharge following delivery, up to 1 week.)
  • Labor and delivery characteristics(From enrollment until discharge following delivery, up to 1 week.)
  • Delivery outcomes and maternal complications(From enrollment until discharge following delivery, up to 1 week.)

研究者

发起方
Yael Yagur
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yael Yagur

Dr Yael Yagur

Meir Medical Center

研究点 (1)

Loading locations...

相似试验